SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-15-008210
Filing Date
2015-09-29
Accepted
2015-09-29 17:23:44
Documents
3
Period of Report
2015-09-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctic-8k_20150929.htm 8-K 49587
2 EX-5.1 ctic-ex51_23.htm EX-5.1 16230
3 EX-10.1 ctic-ex101_6.htm EX-10.1 202475
  Complete submission text file 0001564590-15-008210.txt   269483
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 151131606
SIC: 2834 Pharmaceutical Preparations